XML 137 R6.htm IDEA: XBRL DOCUMENT v3.7.0.1
CONSOLIDATED STATEMENTS OF CHANGES IN SHAREHOLDERS' EQUITY
¥ in Millions, $ in Millions
Total Alibaba Group Holding Limited shareholders' equity (deficits)
IPO
CNY (¥)
Total Alibaba Group Holding Limited shareholders' equity (deficits)
CNY (¥)
Ordinary Shares
IPO
shares
Ordinary Shares
CNY (¥)
shares
Additional paid-in capital
IPO
CNY (¥)
Additional paid-in capital
CNY (¥)
Treasury shares
CNY (¥)
Restructuring reserve
CNY (¥)
Subscription receivables
CNY (¥)
Statutory reserves
CNY (¥)
Cumulative translation adjustments
CNY (¥)
Unrealized gain (loss) on available-for-sale securities, interest rate swaps and others
CNY (¥)
Retained earnings (Accumulated deficits)
CNY (¥)
Noncontrolling interest
CNY (¥)
IPO
CNY (¥)
USD ($)
shares
CNY (¥)
shares
Balance at Mar. 31, 2014   ¥ 29,338   ¥ 1   ¥ 27,043 ¥ 0 ¥ 0 ¥ (540) ¥ 2,474 ¥ (1,144) ¥ 321 ¥ 1,183 ¥ 1,079     ¥ 30,417
Balance (in shares) at Mar. 31, 2014 | shares       2,226,810,660                          
Increase (Decrease) in Stockholders' Equity                                  
Foreign currency translation adjustment   59                 49 10   (7)     52
Net change in unrealized gains on available-for-sale securities   3,089                   3,089         3,089
Change in fair value of interest rate swaps under hedge accounting   (36)                   (36)         (36)
Share of other comprehensive income of equity method investees   13                   13         13
Net income for the year   24,261                     24,261 63     24,324
Liquidation and deconsolidation of subsidiaries                   (26)     26 (378)     (378)
Acquisition of subsidiaries   3,782       3,782               10,897     14,679
Acquisition of subsidiaries (in shares) | shares       8,876,755                          
Exercise of share options and vesting of early exercised options and RSUs, including repayment of related employee loans   676       516     160               676
Exercise of share options and vesting of early exercised options and RSUs, including repayment of related employee loans (in shares) | shares       20,240,334                          
Repurchase and retirement of ordinary shares   (256)       (13)     6       (249)       (256)
Repurchase and retirement of ordinary shares (in shares) | shares       (892,859)                          
Deemed disposals of partial interest in subsidiaries arising from exercise or vesting of share-based awards   (7)       (7)               17     10
Repurchase from, net of subscription, by noncontrolling interest for Partner Capital Investment Plan   (37)             (37)         (86)     (123)
Redemption of treasury shares granted for Senior Management Share Incentive Scheme   15       15               (15)      
Capital injection from noncontrolling interests                           174     174
Amortization of compensation cost   12,659       12,659               291     12,950
Issuance of ordinary shares ¥ 61,536       ¥ 61,536                   ¥ 61,536    
Issuance of ordinary shares (in shares) | shares     149,220,834                            
Excess value receivable arising from the restructuring of the commercial arrangements with Ant Financial Services and related amortization   166       1,318   (1,152)                 166
Conversion of convertible preferred shares   10,293       10,293                     10,293
Conversion of convertible preferred shares (In shares) | shares       91,243,312                          
Accretion to convertible preferred shareholders   (15)                     (15)       (15)
Dividend to convertible preferred shareholders   (97)                     (97)       (97)
Dividend declared by consolidated subsidiaries to noncontrolling interests                           (61)     (61)
Appropriation to statutory reserves                   267     (267)        
Balance at Mar. 31, 2015   145,439   ¥ 1   117,142 0 (1,152) (411) 2,715 (1,095) 3,397 24,842 11,974     157,413
Balance (in shares) at Mar. 31, 2015 | shares       2,495,499,036                          
Increase (Decrease) in Stockholders' Equity                                  
Foreign currency translation adjustment   240             (16)   24 232   56     296
Net change in unrealized gains on available-for-sale securities   1,368                   1,368         1,368
Change in fair value of forward exchange contracts under hedge accounting   (168)                   (168)         (168)
Share of other comprehensive income of equity method investees   65                   65         65
Net income for the year   71,460                     71,460 (158)     71,302
Liquidation and deconsolidation of subsidiaries   21                 21     (10,849)     (10,828)
Acquisition of subsidiaries                           31,409     31,409
Exercise of share options and vesting of early exercised options and RSUs, including repayment of related employee loans   774       519     255               774
Exercise of share options and vesting of early exercised options and RSUs, including repayment of related employee loans (in shares) | shares       25,016,386                          
Repurchase and retirement of ordinary shares   (19,795)       (2,774)             (17,021)       (19,795)
Repurchase and retirement of ordinary shares (in shares) | shares       (46,587,563)                          
Acquisition of additional shares of consolidated subsidiaries   (30)       (30)                     (30)
Redemption of treasury shares granted for Senior Management Share Incentive Scheme   13       13               (13)      
Capital injection from noncontrolling interests                           56     56
Amortization of compensation cost   16,434       16,434               80     16,514
Tax benefits from share-based awards   725       725                     725
Amortization of excess value receivable arising from the restructuring of the commercial arrangements with Ant Financial Services and others   441       177   264                 441
Dividend declared by consolidated subsidiaries to noncontrolling interests                           (3)     (3)
Appropriation to statutory reserves                   529     (529)        
Balance at Mar. 31, 2016   216,987   ¥ 1   132,206 0 (888) (172) 3,244 (1,050) 4,894 78,752 32,552     ¥ 249,539
Balance (in shares) at Mar. 31, 2016 | shares       2,473,927,859                       2,473,927,859 2,473,927,859
Increase (Decrease) in Stockholders' Equity                                  
Foreign currency translation adjustment   (2,307)             (17)   (2,612) 322   99     ¥ (2,208)
Net change in unrealized gains on available-for-sale securities   2,105                   2,105       $ 306 2,105
Share of additional paid-in capital and other comprehensive income of equity method investees   2,199       1,419           780         2,199
Change in fair value of forward exchange contracts under hedge accounting   169                   169       25 169
Change in fair value of interest rate swaps under hedge accounting   433                   433       63 433
Share of other comprehensive income of equity method investees                               113 780
Net income for the year   43,675                     43,675 (488)     43,187
Liquidation and deconsolidation of subsidiaries   44                 44           44
Acquisition of subsidiaries                           9,209     9,209
Exercise of share options and vesting of early exercised options and RSUs, including repayment of related employee loans   701       575     126               701
Exercise of share options and vesting of early exercised options and RSUs, including repayment of related employee loans (in shares) | shares       56,165,655                          
Repurchase and retirement of ordinary shares   (13,182)       (149)             (13,033)       (13,182)
Repurchase and retirement of ordinary shares (in shares) | shares       (27,054,014)                          
Acquisition of additional shares of consolidated subsidiaries   110       110               (450)     (340)
Deemed disposals of partial interest in subsidiaries arising from exercise or vesting of share-based awards   100       100               (58)     42
Redemption of treasury shares granted for Senior Management Share Incentive Scheme   13       13               (13)      
Capital injection from noncontrolling interests                           1,079     1,079
Amortization of compensation cost   15,610       15,610               487     16,097
Tax benefits from share-based awards   689       689                     689
Issuance of ordinary shares   11,189       14,012 (2,823)                   11,189
Issuance of ordinary shares (in shares) | shares       26,324,689                          
Amortization of excess value receivable arising from the restructuring of the commercial arrangements with Ant Financial Services and others   264           264                 264
Exercise of right of subscription by noncontrolling interest for Partner Capital Investment Plan                           100     100
Dividend declared by consolidated subsidiaries to noncontrolling interests                           (187)     (187)
Appropriation to statutory reserves                   836     (836)        
Balance at Mar. 31, 2017   ¥ 278,799   ¥ 1   ¥ 164,585 ¥ (2,823) ¥ (624) ¥ (63) ¥ 4,080 ¥ (3,618) ¥ 8,703 ¥ 108,558 ¥ 42,330   $ 46,654 ¥ 321,129
Balance (in shares) at Mar. 31, 2017 | shares       2,529,364,189                       2,529,364,189 2,529,364,189